Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2025-04-10 00:00:00 ET · period of report 2025-04-09 · accession 0001773751-25-000118 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-04-10 | 2025-04-09 | HIMS | Baird Melissa | COO | S - Sale+OE | $27.32 | -33.3K | 828.2K | -4% | -$910.7K |
| D | 2025-04-10 | 2025-04-09 | HIMS | Baird Melissa | COO | M - OptEx | $1.75 | +33.3K | 838.4K | +4% | +$58.3K |
| D | 2025-04-10 | 2025-04-09 | HIMS | Baird Melissa | COO | M - OptEx | $0.00 | -33.3K | 22.6K | -60% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-04-09 | S | D | 8,392 | $29.23 | 805,083 | D | — | — | (F5) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.85 - $29.545. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 2 | Common | Class A Common Stock | 2025-04-09 | S | D | 3,011 | $28.55 | 813,475 | D | — | — | (F4) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.805 - $28.775. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Class A Common Stock | 2025-04-09 | S | D | 11,735 | $26.94 | 816,486 | D | — | — | (F3) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $26.645 - $27.51. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 4 | Common | Class A Common Stock | 2025-04-09 | S | D | 10,199 | $25.82 | 828,221 | D | — | — | (F2) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $25.56 - $26.355. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 5 | Common | Class A Common Stock | 2025-04-09 | M | A | 33,337 | $1.75 | 838,420 | D | — | — | |
| 6 | Derivative | Stock Option (right to buy) | 2025-04-09 | M | D | 33,337 | $0.00 | 22,569 | D | $1.75 · — to 2029-11-06 | 33,337 Class A Common Stock | (F6) Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 250,000 shares of Hims, Inc., with an exercise price of $0.79. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 113,245 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested. |